Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Gene Expression Level Detection: Principles, Methods, and Applications

Gene expression level detection quantifies the transcriptional activity of target genes by measuring mRNA and other RNA species in biological samples, delivering essential data for disease diagnosis, drug development, and life science research. Accredited third-party laboratories provide comprehensive gene expression analysis services using validated platforms such as quantitative real-time PCR, RNA sequencing, and microarray technology. This article presents the technical principles, sample requirements, testing workflows, quality standards, and typical applications of gene expression level detection.

Technical Overview

Gene expression level detection is the quantitative and qualitative analysis of gene transcription products, primarily messenger RNA (mRNA), and in certain contexts the corresponding protein products, in order to determine the functional activity of specific genes within a biological sample. Because changes in gene expression patterns directly reflect cellular state, physiological condition, disease progression, and response to external stimuli, accurate measurement of expression levels has become a cornerstone of modern molecular biology, clinical diagnostics, and biopharmaceutical development.

The detection process typically encompasses sample collection and stabilization, RNA extraction and quality control, reverse transcription, signal amplification or hybridization, quantitative analysis, and statistical interpretation. Reliable results depend on strict control of pre-analytical variables, rigorous RNA integrity assessment, appropriate normalization strategies using reference genes, and adherence to internationally recognized reporting guidelines such as the MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) guidelines and quality management standards including ISO/IEC 17025 for testing laboratories and ISO 15189 for medical laboratories.

Testing Samples

Animal and Human Tissues

Fresh, flash-frozen, and formalin-fixed paraffin-embedded (FFPE) tissues are among the most common sample types. Frozen tissues generally yield high-quality intact RNA, while FFPE samples, although partially fragmented, can be analyzed using optimized extraction and amplification protocols developed specifically for degraded RNA. Tissue specimens must be collected rapidly and preserved under RNase-free conditions to prevent degradation.

Blood and Body Fluids

Whole blood collected in EDTA or specialized RNA-stabilizing tubes, peripheral blood mononuclear cells (PBMCs), plasma, serum, saliva, urine, and cerebrospinal fluid can all serve as detection substrates. Blood samples are particularly valuable for minimally invasive monitoring of immune-related transcripts and circulating biomarkers such as cell-free RNA.

Cultured Cells

Cell lines and primary cultures from research or production settings can be submitted as cell pellets, viable suspensions, or lysates directly stabilized in RNA-preserving reagents. Cell-based samples are widely used in functional genomics studies, drug screening programs, and cell therapy characterization.

Plant and Microbial Samples

Plant tissues, seeds, microbial cultures, and environmental isolates are accepted for expression analysis in agricultural biotechnology, GMO evaluation, and microbial functional studies. These sample types often require specialized homogenization and extraction chemistry to overcome polysaccharides, polyphenols, and rigid cell walls.

Purified RNA

Clients may submit previously extracted total RNA or mRNA, provided the material meets minimum purity and integrity thresholds, typically an A260/A280 ratio between 1.8 and 2.1 and an RNA Integrity Number (RIN) of 7 or above for most downstream applications.

Testing Items

Gene expression level detection services generally cover the following analytical categories:

  • Single-gene and multi-gene mRNA expression quantification, reported as absolute copy number or relative fold change against calibrated controls.
  • Differential expression analysis comparing experimental groups, such as treated versus untreated, diseased versus healthy, or transgenic versus wild type.
  • Non-coding RNA profiling, including microRNA (miRNA), long non-coding RNA (lncRNA), and circular RNA (circRNA) expression measurements.
  • Whole-transcriptome expression screening for discovery-oriented projects involving thousands to tens of thousands of targets simultaneously.
  • Reference gene validation and normalization assessment to confirm stable endogenous controls for the specific tissue or experimental system under investigation.
  • Gene expression signature analysis supporting molecular subtyping, prognosis prediction, and pharmacodynamic monitoring.

Testing Methods

Quantitative Real-Time PCR (qRT-PCR)

Reverse transcription quantitative PCR is the gold-standard method for targeted gene expression quantification owing to its exceptional sensitivity, wide dynamic range, and low sample requirement. RNA is reverse-transcribed into cDNA and amplified with gene-specific primers and fluorescent detection chemistry. Quantification follows the comparative Ct method or absolute quantification against standard curves. Workflows compliant with MIQE guidelines include melt-curve verification, amplification efficiency validation, and replicate consistency checks.

RNA Sequencing (RNA-Seq)

Next-generation RNA sequencing provides unbiased, genome-wide expression profiling with single-base resolution. RNA-Seq detects novel transcripts, alternative splicing events, fusion transcripts, and allele-specific expression, making it the preferred platform for discovery research. Both bulk RNA-Seq and single-cell RNA-Seq workflows are available, with library preparation adapted to total RNA, mRNA-enriched, or small RNA inputs.

Microarray Analysis

DNA microarrays enable simultaneous hybridization-based measurement of tens of thousands of predefined transcripts. Although largely supplemented by RNA-Seq for discovery work, microarrays remain cost-effective for high-throughput screening with well-characterized gene panels and for applications requiring standardized, reproducible panels.

Digital PCR (dPCR/ddPCR)

Droplet digital PCR partitions reactions into thousands of individual compartments, enabling absolute quantification without standard curves. This method delivers superior precision for low-abundance transcripts and small fold-change discrimination, which is valuable for validating candidate biomarkers identified by screening approaches.

Northern Blotting and In Situ Hybridization

Northern blotting remains a confirmatory technique that reveals transcript size and integrity, while RNA in situ hybridization localizes expression directly within tissue sections, preserving spatial context that is lost in bulk extraction methods.

Quality Control and Data Reporting

Accredited third-party laboratories implement comprehensive quality systems covering RNA integrity assessment, no-template and no-reverse-transcriptase controls, calibration verification, and bioinformatics validation for sequencing data. Final reports include raw data, quality metrics, normalized expression values, statistical significance, and interpretive summaries aligned with client-specified acceptance criteria.

Applications

Gene expression level detection supports decision-making across a broad spectrum of scientific and industrial domains:

  • Clinical diagnostics and oncology: companion diagnostic testing for therapy selection, tumor molecular subtyping, minimal residual disease monitoring, and prognostic gene signature evaluation.
  • Pharmaceutical research and development: target identification and validation, pharmacodynamic biomarker measurement, toxicogenomic screening, and batch characterization of biopharmaceutical production cell lines.
  • Cell and gene therapy: verification of transgene expression, pluripotency marker monitoring in stem cell products, and potency assay development.
  • Agricultural and environmental biotechnology: transgene expression confirmation, stress-response studies in crops, and microbial community functional analysis.
  • Food safety and authenticity: species identification and verification of processing-induced molecular changes in food matrices.
  • Basic life science research: mechanistic studies of signaling pathways, developmental biology, immunology, and neuroscience.

FAQ

How much sample is required for gene expression analysis?

Typical input requirements range from 10 to 100 mg of tissue, 105 to 107 cells, or 100 to 500 ng of purified RNA for targeted qRT-PCR assays, while RNA-Seq generally requires 100 ng to 1 µg of high-quality total RNA. Low-input and single-cell protocols can accommodate substantially reduced quantities.

What RNA quality is acceptable for testing?

A RIN of 7 or higher is recommended for RNA-Seq and most quantitative applications, whereas qRT-PCR assays designed with short amplicons can often tolerate partially degraded RNA, including material extracted from FFPE blocks.

How long does gene expression testing take?

Standard targeted qRT-PCR projects are commonly completed within 5 to 10 working days after sample acceptance, whereas full transcriptome sequencing projects, including library preparation, sequencing, and bioinformatic analysis, typically require 2 to 4 weeks.

Which method should be chosen for a given project?

qRT-PCR is optimal for confirming a small number of predefined targets with high sensitivity; RNA-Seq suits discovery projects requiring unbiased, genome-wide coverage; microarrays offer economical high-throughput screening; and digital PCR provides the greatest precision for rare transcripts and subtle expression differences. Technical consultants at accredited third-party laboratories can recommend the most appropriate platform based on project objectives, sample type, and budget.

How is data normalized across samples?

Expression values are normalized against validated reference genes, such as ACTB, GAPDH, or 18S rRNA, selected for stability in the specific experimental system, supplemented by external spike-in controls where appropriate. Sequencing data additionally undergo library size normalization through established bioinformatic algorithms.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing